Estradiol benzoate/progesterone/methandriol dipropionate (EB/P4/MADP), sold under the brand name Progestandron (Organon), is an injectable combination medication of estradiol benzoate (EB), an estrogen, progesterone (P4), a progestogen, and methandriol dipropionate (MADP), an androgen/anabolic steroid.[1][2] It contained 3 mg EB, 20 mg P4, and 50 mg MADP, was provided in the form of ampoules, and was administered by intramuscular injection.[1][2] The medication was marketed by 1957.[1] It is no longer available.[3]
| Combination of | |
|---|---|
| Estradiol benzoate | Estrogen |
| Progesterone | Progestogen |
| Methandriol dipropionate | Androgen; Anabolic steroid |
| Clinical data | |
| Trade names | Progestandron |
| Other names | EB/P4/MADP |
| Routes of administration | Intramuscular injection |
See also edit
References edit
- ^ a b c Silló G (1958). "Komplexhormon bei Menopause und Hypertonie". Hormone und Psyche die Endokrinologie des Alternden Menschen: Fünftes Symposion der Deutschen Gesellschaft für Endokrinologie Freiburg (Breisgau), den 7. bis 9. März 1957. Springer. pp. 53–57. doi:10.1007/978-3-642-87014-9_9. ISBN 978-3-642-87014-9.
- ^ a b Ufer J (1960). Hormontherapie in der Frauenheilkunde: Grundlagen und Praxis. Gruyter. p. 155. ISBN 9783111138770.
- ^ "Progestandron". drugs.com.[permanent dead link]
 | This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |